APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multivalent Oral Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Multivalent Oral Rotavirus Vaccine Market Outlook and Growth Opportunities 2026

29 December 2025199 pages

Choose your research edition.

Industry ResearchMultivalent Oral Rotavirus Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Multivalent Oral Rotavirus Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Multivalent Oral Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multivalent Oral Rotavirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Multivalent Oral Rotavirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Multivalent Oral Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Multivalent Oral Rotavirus Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Multivalent Oral Rotavirus Vaccine market include Serum Institute of India, Lanzhou Institute of Biological Products and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Multivalent Oral Rotavirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multivalent Oral Rotavirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multivalent Oral Rotavirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Multivalent Oral Rotavirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Multivalent Oral Rotavirus Vaccine Segment by Company

Serum Institute of India

Lanzhou Institute of Biological Products

Merck

Multivalent Oral Rotavirus Vaccine Segment by Type

RV3

RV5

Multivalent Oral Rotavirus Vaccine Segment by Application

Government Institution

Private Sector

Other

Multivalent Oral Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Multivalent Oral Rotavirus Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Multivalent Oral Rotavirus Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Multivalent Oral Rotavirus Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Multivalent Oral Rotavirus Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multivalent Oral Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multivalent Oral Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multivalent Oral Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Multivalent Oral Rotavirus Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multivalent Oral Rotavirus Vaccine industry.

Chapter 3: Detailed analysis of Multivalent Oral Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Multivalent Oral Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Multivalent Oral Rotavirus Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Multivalent Oral Rotavirus Vaccine Industry Trends Table 2. Multivalent Oral Rotavirus Vaccine Industry Drivers Table 3. Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges Table 4. Multivalent Oral Rotavirus Vaccine Industry Restraints Table 5. Global Multivalent Oral Rotavirus Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Multivalent Oral Rotavirus Vaccine Revenue Share by Company (2021-2026) Table 7. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Multivalent Oral Rotavirus Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Multivalent Oral Rotavirus Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Multivalent Oral Rotavirus Vaccine Company, Product Type & Application Table 13. Global Multivalent Oral Rotavirus Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Multivalent Oral Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of RV3 Table 18. Significant Companies of RV5 Table 19. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Multivalent Oral Rotavirus Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Multivalent Oral Rotavirus Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Multivalent Oral Rotavirus Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Government Institution Table 30. Significant Companies of Private Sector Table 31. Significant Companies of Other Table 32. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Multivalent Oral Rotavirus Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Multivalent Oral Rotavirus Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Multivalent Oral Rotavirus Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Multivalent Oral Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Multivalent Oral Rotavirus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Multivalent Oral Rotavirus Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Multivalent Oral Rotavirus Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Multivalent Oral Rotavirus Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Multivalent Oral Rotavirus Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Multivalent Oral Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Multivalent Oral Rotavirus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Multivalent Oral Rotavirus Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Multivalent Oral Rotavirus Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Multivalent Oral Rotavirus Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Multivalent Oral Rotavirus Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Serum Institute of India Company Information Table 65. Serum Institute of India Business Overview Table 66. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio Table 68. Serum Institute of India Recent Development Table 69. Lanzhou Institute of Biological Products Company Information Table 70. Lanzhou Institute of Biological Products Business Overview Table 71. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio Table 73. Lanzhou Institute of Biological Products Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck Multivalent Oral Rotavirus Vaccine Product Portfolio Table 78. Merck Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Multivalent Oral Rotavirus Vaccine Distributors List Table 82. Multivalent Oral Rotavirus Vaccine Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Multivalent Oral Rotavirus Vaccine Product Image Figure 2. Global Multivalent Oral Rotavirus Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Multivalent Oral Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Multivalent Oral Rotavirus Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Multivalent Oral Rotavirus Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. RV3 Image Figure 10. RV5 Image Figure 11. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Multivalent Oral Rotavirus Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Multivalent Oral Rotavirus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Type (2021-2032) Figure 17. Government Institution Image Figure 18. Private Sector Image Figure 19. Other Image Figure 20. Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Multivalent Oral Rotavirus Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Multivalent Oral Rotavirus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Multivalent Oral Rotavirus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Multivalent Oral Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Multivalent Oral Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Multivalent Oral Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Multivalent Oral Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Multivalent Oral Rotavirus Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Multivalent Oral Rotavirus Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • RV3
  • RV5
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Serum Institute of India
  • Lanzhou Institute of Biological Products
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Multivalent Oral Rotavirus Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Multivalent Oral Rotavirus Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Multivalent Oral Rotavirus Vaccine Market Dynamics
  1. 2.1 Multivalent Oral Rotavirus Vaccine Industry Trends
  2. 2.2 Multivalent Oral Rotavirus Vaccine Industry Drivers
  3. 2.3 Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Multivalent Oral Rotavirus Vaccine Industry Restraints
3 Multivalent Oral Rotavirus Vaccine Market by Company
  1. 3.1 Global Multivalent Oral Rotavirus Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Multivalent Oral Rotavirus Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Multivalent Oral Rotavirus Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Multivalent Oral Rotavirus Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Multivalent Oral Rotavirus Vaccine Company Product Type and Application
  8. 3.8 Global Multivalent Oral Rotavirus Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Multivalent Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Multivalent Oral Rotavirus Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Multivalent Oral Rotavirus Vaccine Market by Type
  1. 4.1 Multivalent Oral Rotavirus Vaccine Type Introduction
  2. 4.1.1 RV3
  3. 4.1.2 RV5
  4. 4.2 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type
  5. 4.2.1 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Multivalent Oral Rotavirus Vaccine Sales Value by Type
  9. 4.3.1 Global Multivalent Oral Rotavirus Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Multivalent Oral Rotavirus Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Type (2021-2032)
5 Multivalent Oral Rotavirus Vaccine Market by Application
  1. 5.1 Multivalent Oral Rotavirus Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application
  6. 5.2.1 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Multivalent Oral Rotavirus Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Multivalent Oral Rotavirus Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Multivalent Oral Rotavirus Vaccine Sales Value by Application
  10. 5.3.1 Global Multivalent Oral Rotavirus Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Multivalent Oral Rotavirus Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Multivalent Oral Rotavirus Vaccine Sales Value Share by Application (2021-2032)
6 Multivalent Oral Rotavirus Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Multivalent Oral Rotavirus Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Multivalent Oral Rotavirus Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Multivalent Oral Rotavirus Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Multivalent Oral Rotavirus Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Multivalent Oral Rotavirus Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Multivalent Oral Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Multivalent Oral Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Multivalent Oral Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Multivalent Oral Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Multivalent Oral Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
7 Multivalent Oral Rotavirus Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Multivalent Oral Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Multivalent Oral Rotavirus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Multivalent Oral Rotavirus Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Multivalent Oral Rotavirus Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Multivalent Oral Rotavirus Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Multivalent Oral Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Multivalent Oral Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Multivalent Oral Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Serum Institute of India
  2. 8.1.1 Serum Institute of India Company Information
  3. 8.1.2 Serum Institute of India Business Overview
  4. 8.1.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio
  6. 8.1.5 Serum Institute of India Recent Developments
  7. 8.2 Lanzhou Institute of Biological Products
  8. 8.2.1 Lanzhou Institute of Biological Products Company Information
  9. 8.2.2 Lanzhou Institute of Biological Products Business Overview
  10. 8.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio
  12. 8.2.5 Lanzhou Institute of Biological Products Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Multivalent Oral Rotavirus Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Multivalent Oral Rotavirus Vaccine Value Chain Analysis
  2. 9.1.1 Multivalent Oral Rotavirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Multivalent Oral Rotavirus Vaccine Sales Mode & Process
  6. 9.2 Multivalent Oral Rotavirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Multivalent Oral Rotavirus Vaccine Distributors
  9. 9.2.3 Multivalent Oral Rotavirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst